In-hospital mortality was significantly lower in patients aged 90 years or older treated with PCI compared with medical management.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transglutaminase 2 (TGM2) has ...

SAN FRANCISCO, California — A small, phase 2 study, with a biomarker test for its primary end point, offers some encouraging hints that the P-selectin antagonist inclacumab may be able to reduce ...

Current guidelines recommend dual antiplatelet therapy, a combination of aspirin and a P2Y 12 inhibitor, for 6–12 months after percutaneous coronary intervention with drug-eluting stent implantation ...

Acute coronary syndrome (ACS) in younger patients presents distinctive epidemiological and clinical patterns when compared with older cohorts. Although traditionally viewed as a disease of older ...

Please provide your email address to receive an email when new articles are posted on . A guideline for managing patients with acute coronary syndrome was issued by several U.S. societies. The ...

The American College of Cardiology and the American Heart Association today released an updated clinical practice guideline for managing individuals experiencing acute coronary syndrome (ACS). The ...

PARIS, France—Among patients with acute MI and occlusive disease on invasive angiography, those presenting without ST-segment elevation on the initial ECG fare worse than those with STEMI, researchers ...

The diagnostics advisory committee considered evidence on high-sensitivity troponin tests for the early rule out of non-ST-segment elevation myocardial infarction (NSTEMI) from several sources. Full ...

Please provide your email address to receive an email when new articles are posted on . Telehealth visits with CV care teams reduced unnecessary readmissions after acute coronary syndrome. Patients ...

Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome. HealthDay News — For patients with acute coronary syndrome (ACS) undergoing drug-eluting ...